Rationale and Design of the Turkish Sleep Apnea Database - TURKAPNE: A National, Multicenter, Observational, Prospective Cohort Study
Makaleler > Tam Makale · 2018
Yazarlar: Yuksel Peker, Özen KAÇMAZ BAŞOĞLU, Hikmet Firat, Ahmet Ursavas, Aylin Ozsancak Ugurlu, Baran Balcan, Bugra Kerget, Demet Ilhan Algin, Derya Karadeniz, Dursun Dursunoglu, Ersin Gunay, Fuat Erel, Gokhan Kirbas, Gulcin Benbir Senel, Gulgun Cetintas Afsar, Gulin Melikoglu, Hadice Selimoglu Sen, Hamza Ogun, Ibrahim Oztura, Mehmet Ali Habesoglu, Mehmet Karadag, Mehmet Sezai TAŞBAKAN, Melike Banu Yuceege, Metin Akgun, Muhammed Emin Akkoyunlu, Murat Aksu, Nejat Altintas, Nese Dursunoglu, Nurhan Sarioglu, Oguz Osman Erdinc, Oya Itil, Ozgur Bilgin Topcuoglu, Pinar Bekdik Sirinocak, Sema Sarac, Sevgi Ferik, Sibel Pekcan, Sureyya Yilmaz, Yildiz Kaya, Zahide Yilmaz
Turkish Thoracic Journal, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Scopus, 2018, cilt 19, ss 136-140
DOI: 10.5152/turkthoracj.2018.18097
Özet
OBJECTIVES: The primary aim of The Turkish Sleep Apnea Database (TURKAPNE) study is to generate a cross-sectional nationwide database for defining the clinical and polysomnographic characteristics of the patients with obstructive sleep apnea (OSA) in Turkey. MATERIALS AND METHODS: In this ongoing project, all consecutive adults with suspected OSA are recruited from the sleep centers of the university and research hospitals in Turkey. Information on anthropometric data, educational status, driving license, smoking habits, alcohol use, comorbidities, drug use, questionnaires, polysomnographic, and/or cardiorespiratory polygraphic findings are recorded in a systematized Web-based report form. Blood glucose, lipids and other biochemical markers, lung function, and echocardiography measurements are optionally included. Follow-up data regarding treatment modality and compliance is assessed. Cross-sectional and longitudinal associations between OSA phenotypes and metabolic, pulmonary, and cardiovascular comorbidities as well as traffic accidents, and the impact of treatment will be further explored. We target a total sample of 10,000 participants. RESULTS: The study was registered with ClinicalTrials.gov (NCT02784977) in May 2016 and the first patient was recruited in October 2017. A total of 1911 participants from 19 centers have been enrolled in the study by May 31, 2018. CONCLUSION: The TURKAPNE study will contribute to a better understanding of the health-related burden of OSA phenotypes and its association with the comorbidities and adverse outcomes, including traffic accidents in Turkey. The results may also contribute to a more personalized approach and better management of varying OSA phenotypes with concomitant disorders.